Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



New Products

Related to Stem Cell-Modifying Antibodies for Regenerative Therapies

    • Stem Cell Growth
    • Life Technologies
    • Gibco® KnockOut™ CTS™ SR Growth Factor cocktail and KnockOut CTS ESC/iPSC XenoFree kits enable feeder and feeder-free growth of human embryonic stem cells (hESCs) and induced pluripotent stem cells (iPSCs). The KnockOut SR GF cocktail is sold
    • iPSC Media
    • Life Technologies
    • Existing feeder-free culture media can contain more than 20 interactive ingredients, many of which, such as bovine serum albumin (BSA) and lipids, are highly uncharacterized and vary significantly from lot to lot. Made in partnership with Cellular
    • Stem Cell Culture Medium
    • STEMCELL Technologies
    • TeSR™-E8™ is a feeder-free culture medium for human embryonic stem cells (ES cells) and human induced pluripotent stem cells (iPS cells). TeSR-E8 contains only the essential eight components required for maintenance of ES cells and iPS cells. TeSR-
    • Mouse Monoclonal IgM Antibody
    • ANP Technologies
    • ANPEG-1 is a mouse monoclonal IgM antibody developed using a linear 40 kDa PEG polymer immunogen. It has been used as a positive control antibody in double-bridging immunogenicity assays in both ELISA and LFA formats. ANPEG-1 can be used as either
    • Hematopoietic Differentiation Medium
    • Primorigen Biosciences
    • The MesoTotal™ HPC/HSC differentiation system is a new medium and protocol for high efficiency differentiation of human pluripotent stem cells into hematopoietic progenitor cells (CD45/43+ and CD34+) and hematopoietic stem cells (CD45/43+, CD34+, C
    • Monoclonal Antibodies
    • Beckman Coulter
    • Fourteen new human monoclonal antibodies are now available through a partnership with Trillium Diagnostics including human anti-hemoglobin F, which recognizes fetal hemoglobin molecules; CD163 markers for anti-inflammatory signal and disease resear
    • HCP Antibodies
    • Rockland Immunochemicals
    • Host-cell protein (HCP) antibodies that detect high, medium, and low-molecular weight proteins are now available. Host-cell proteins are process-related impurities derived from a host-cell expression system that may be present in trace amounts in a
    • Stem Cell Lines
    • Genea Stem Cells
    • Embryonic pluripotent cell lines are available including one disease free pluripotent cell line and 24 others with individual mutations that can give rise to several severe diseases such as cancer (breast cancer, Wilm’s tumor, and Von Hippel–Lindau
    • Monoclonal Antibodies
    • Trevigen
    • XPF/ERCC1 forms a heterodimer complex and catalyzes 5’ incision to the DNA damage during nucleotide excision repair. ERCC1/XPF is also required for repair of DNA interstrand crosslinks and involved in repair of double-strand breaks. A monoclonal XP
    • Antibody Microarray Kit
    • Kinexus
    • The Kinex™ 850-antibody microarray tracks the levels and functional states of many diverse proteins in human and animal cell and tissue specimens and features more than 330 phosphosite and 540 pan-specific antibody probes. This can provide research
    • Hematopoietic Colony Imaging System
    • STEMCELL Technologies
    • STEMvision™ is a bench-top instrument and computer system designed specifically for automated imaging and counting of hematopoietic colonies in the colony-forming unit assay. This system is meant to be used with MethoCult™ media and meniscus-free S
    • Antibody Arrays
    • R&D Systems
    • With Proteome Profiler Antibody Arrays, instead of performing multiple Western blots, users can start their experiments by profiling their lysates for up to 59 phospho-proteins in a single sample. Proteome Profiler Antibody Arrays can reveal relati
  • Page 1 of 1 (13 items) 1 

GEN Poll

More » Poll Results » Archive »

Genome Sequencing and Patient Autonomy

Do you think ACMG’s recent recommendations for reporting incidental clinical sequencing results undermine patient autonomy?

Suggest a Poll